Autopsy report · NCT05101798

The Role of 5-Aminolevulinic Acid Fluorescence-Guided Surgery in Head and Neck Cancers: a Pilot Trial

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“NX Development Corporation closed the trial”

The sponsor’s own words in the registry.

Life of this trial

Registered 1 month after it had already started.
Ran for about 1 year 3 months before it stopped.
7 participants enrolled.
Results were posted on the registry 2 years 7 months after it ended.

Vital statistics

Status: Terminated
Phase: Phase 2
Sponsor: Icahn School of Medicine at Mount Sinai
Sponsor type: University, hospital or other
Conditions: Neoplasm; Skull Base Neoplasm
Interventions: 5-Aminolevulinic acid Hydrochloride
Participants: 7
Sites: 3
Countries: United States

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.